The review "From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction" explores the complex pathophysiology of sepsis and its impact on multiple organ systems. Sepsis is a life-threatening condition caused by a dysregulated systemic inflammatory response to infection, leading to organ dysfunction, septic shock, and death. The review highlights the key molecular mechanisms involved, including inflammation, oxidative stress, endothelial dysfunction, mitochondrial damage, and dysbiosis. These factors contribute to the development of multiple organ failure, which is a major cause of mortality in sepsis patients. The review discusses various therapeutic approaches, including melatonin, metformin, palmitoylethanolamide (PEA), herbal extracts, and gut microbiota modulators, which have shown efficacy in different sepsis models. Recent research has shifted focus from anti-inflammatory and antioxidant agents to exploring energy metabolism and gut microbiota modulation in sepsis. These approaches have shown significant impact in preventing multiple organ damage and mortality in animal models but require further clinical investigation. The review also covers the pathophysiology of sepsis, including the role of inflammation and oxidative stress in the development of sepsis. It discusses the involvement of Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in the initiation of sepsis-related inflammation. The activation of these receptors leads to the production of inflammatory mediators and the development of pro-inflammatory, pro-apoptotic, pro-adhesive, and pro-coagulant phenotypes. The review further examines sepsis-related endothelial dysfunction, which contributes to organ damage and sepsis-induced coagulopathy. It highlights the importance of understanding the complex interactions between inflammation, oxidative stress, endothelial dysfunction, and mitochondrial damage in the pathogenesis of sepsis. The review also discusses the treatment strategies for sepsis, including early diagnosis, antimicrobial therapy, pharmacological approaches, metabolic support, and septic shock treatment. It emphasizes the need for a comprehensive understanding of sepsis pathophysiology to develop effective therapeutic strategies. The review concludes that further research is needed to improve the treatment of sepsis and reduce its high mortality rate.The review "From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction" explores the complex pathophysiology of sepsis and its impact on multiple organ systems. Sepsis is a life-threatening condition caused by a dysregulated systemic inflammatory response to infection, leading to organ dysfunction, septic shock, and death. The review highlights the key molecular mechanisms involved, including inflammation, oxidative stress, endothelial dysfunction, mitochondrial damage, and dysbiosis. These factors contribute to the development of multiple organ failure, which is a major cause of mortality in sepsis patients. The review discusses various therapeutic approaches, including melatonin, metformin, palmitoylethanolamide (PEA), herbal extracts, and gut microbiota modulators, which have shown efficacy in different sepsis models. Recent research has shifted focus from anti-inflammatory and antioxidant agents to exploring energy metabolism and gut microbiota modulation in sepsis. These approaches have shown significant impact in preventing multiple organ damage and mortality in animal models but require further clinical investigation. The review also covers the pathophysiology of sepsis, including the role of inflammation and oxidative stress in the development of sepsis. It discusses the involvement of Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in the initiation of sepsis-related inflammation. The activation of these receptors leads to the production of inflammatory mediators and the development of pro-inflammatory, pro-apoptotic, pro-adhesive, and pro-coagulant phenotypes. The review further examines sepsis-related endothelial dysfunction, which contributes to organ damage and sepsis-induced coagulopathy. It highlights the importance of understanding the complex interactions between inflammation, oxidative stress, endothelial dysfunction, and mitochondrial damage in the pathogenesis of sepsis. The review also discusses the treatment strategies for sepsis, including early diagnosis, antimicrobial therapy, pharmacological approaches, metabolic support, and septic shock treatment. It emphasizes the need for a comprehensive understanding of sepsis pathophysiology to develop effective therapeutic strategies. The review concludes that further research is needed to improve the treatment of sepsis and reduce its high mortality rate.